Ropivacaine
- Generic Name
- Ropivacaine
- Brand Names
- Naropin
- Drug Type
- Small Molecule
- Chemical Formula
- C17H26N2O
- CAS Number
- 84057-95-4
- Unique Ingredient Identifier
- 7IO5LYA57N
- Background
Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
- Indication
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
- Associated Conditions
- Acute Pain, Postoperative pain
- Associated Therapies
- Surgical anesthesia therapy
Comparison of Ropivacaine and Levobupivacaine in High Thoracic Epidural Anesthesia
- Conditions
- Interventions
- First Posted Date
- 2007-11-02
- Last Posted Date
- 2007-11-02
- Lead Sponsor
- Centro Cardiologico Monzino
- Target Recruit Count
- 61
- Registration Number
- NCT00552864
- Locations
- 🇮🇹
Department of Anesthesia & ICU. IRCCS Centro Cardiologico Monzino, Milano, Italy
Evaluate the Use of Paravertebral Block in Reconstructive Breast Surgery
- Conditions
- Interventions
- First Posted Date
- 2007-10-11
- Last Posted Date
- 2015-04-13
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 89
- Registration Number
- NCT00542542
- Locations
- 🇺🇸
UT MD Anderson Cancer Center, Houston, Texas, United States
Postoperative Analgesia With Local Infiltration After Femoral Neck Fracture
- First Posted Date
- 2007-09-14
- Last Posted Date
- 2010-05-06
- Lead Sponsor
- Odense University Hospital
- Target Recruit Count
- 50
- Registration Number
- NCT00529425
- Locations
- 🇩🇰
Odense University Hospital, Odense, Denmark
Cardiovascular Safety Research: Bupivacaine With Vasoconstrictor Versus Ropivacaine in Brachial Plexus Block
- Conditions
- Interventions
- First Posted Date
- 2007-08-31
- Last Posted Date
- 2009-02-19
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 48
- Registration Number
- NCT00523289
Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone, Plus Systemic Dexamethasone
- Conditions
- Interventions
- First Posted Date
- 2007-08-22
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- The Cleveland Clinic
- Target Recruit Count
- 218
- Registration Number
- NCT00519584
- Locations
- 🇺🇸
Cleveland Clinic Hillcrest, Cleveland, Ohio, United States
🇺🇸Cleveland Clinic /Euclid Hospital, Euclid, Ohio, United States
Pain Relief by Intra-Peritoneal Ropivacaine During Gynecological Laparoscopy
- Conditions
- Interventions
- First Posted Date
- 2007-02-09
- Last Posted Date
- 2008-06-20
- Lead Sponsor
- Carmel Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00433316
- Locations
- 🇮🇱
the Carmel Medical Center Ambulatory Gynecoendoscopic Unit, Haifa, Israel
Ropivacaine Versus Bupivacaine for Spinal Anaesthesia in Patients Undergoing Unilateral Lower Limb Surgery
- Conditions
- First Posted Date
- 2006-07-31
- Last Posted Date
- 2009-03-26
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 220
- Registration Number
- NCT00358280
- Locations
- 🇨🇳
Research Site, Xi'an, China
Epidural Analgesia or Patient-Controlled Analgesia in Treating Patients Who Have Undergone Surgery for Gynecologic Cancer
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2014-05-20
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 240
- Registration Number
- NCT00295945
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
Analgesic Efficacy of Inter Pleural Ropivacaine Road in Post Thoracotomy Pain for Oncologic Surgery
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-11-26
- Lead Sponsor
- Institut Bergonié
- Target Recruit Count
- 90
- Registration Number
- NCT00210132
- Locations
- 🇫🇷
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest, Bordeaux, France
Evaluation of Efficacy of Lumbar Plexus Bloc After Hip Surgery
- Conditions
- First Posted Date
- 2005-09-08
- Last Posted Date
- 2017-11-01
- Lead Sponsor
- University Hospital, Angers
- Target Recruit Count
- 60
- Registration Number
- NCT00150865
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.